SCIENCE NEWS McGill Discovery Offers Hope in Diabetes The team discovered mutations in the unstudied gene called RFX6 and found that these mutations are the cause of a rare syndrome of neonatal diabetes involving the complete absence of islets of Langerhans. [Press release from McGill University discussing the online prepublication in Nature] Biologists Image Birth of Blood-Forming Stem Cells in Embryo Biologists have identified the specific region in vertebrates where adult blood stem cells arise during embryonic development. [Press release from EurekaAlert! discussing the online prepublication in Nature] Induced Pluripotent Stem Cells Not Yet Reliable for Clinical Use A new study comparing the ability of induced cells and embryonic cells to morph into the cells of the brain has found that induced cells – even those free of the genetic factors used to program their all-purpose qualities – differentiate less efficiently and faithfully than their embryonic counterparts. [Press release from the University of Wisconsin School of Medicine and Public Health discussing the online prepublication in the Proceedings of the National Academy of Sciences] ‘Death’ Proteins Help Stem Cells Develop: Study Stem cells that can repair and regenerate tissues may need to get their DNA chopped up as a normal part of growing up and turning into specialized cells like muscle cells, Ottawa researchers have found. [Press release from the Canadian Broadcasting Corporation discussing the online prepublication in the Proceedings of the National Academy of Sciences]
|
|
INDUSTRY NEWS Living Cell Technologies Awarded NZ$4.04 Million New Zealand Government Grant to Advance DIABECELL® for Type 1 Diabetes Cell implant company Living Cell Technologies Limited announced that it has been awarded a grant of NZ$4.04 million from the New Zealand government’s Foundation for Research Science & Technology. [Living Cell Technologies Limited Press Release] Athersys Receives United States Patent Covering Adult Stem Cell Composition & Production Athersys, Inc. announced that it has been granted U.S. patent 7,659,118 that covers non-embryonic multipotent stem cells, their isolation and expansion, and related pharmaceutical compositions. [Athersys, Inc. Press Release] £6 Million to be Invested in Further Regenerative Medicine Research and Development The Technology Strategy Board is to invest a further £6 million in regenerative medicine research and development and has invited British companies to bid for funding through two new competitions. [Technology Strategy Board Press Release] University of California, Irvine Seeks $15 Million for ‘Mouse House’ University of California, Irvine says it has asked the federal government for $15 million to create a major vivarium, or rodent housing facility, in the $66 million stem cell research institute that’s scheduled to open on campus in July. [The Orange County Register] Portland Development Commission Spends $800,000 for Bioscience ‘Wet Labs’ Oregon’s biotech community will soon have access to four wet labs, where early stage companies can test and analyze chemicals and drugs. [Portland Business Journal]
|
|
POLICY NEWS Bills to Modify Stem Cell Amendment Held Up in Senate A package of six bills to modify Michigan’s constitutional amendment that permits embryonic stem cell research appears to be stalled in the Senate because Majority Leader Mike Bishop is concerned the changes could lead to job losses and may not reflect voters’ intent in voting for the amendment. [Michigan Senate, United States] Food and Drug Administration Budget Draws Cries of ‘Not Enough’ A coalition of interests will push for more money, saying chronic underfunding has led to failures at the agency and that society, not just companies, are affected. [Food and Drug Administration, United States] National Institutes of Health Grants to Children’s Hospital Will Advance Novel Stem Cell Treatments for Blood Disorders Two large federal grants recently awarded to The Children’s Hospital of Philadelphia will advance the frontiers of research into cellular therapies. [National Institutes of Health, United States] Delays in Grant Application Submission due to Widespread Winter Storm (NOT-OD-10-061) [National Institutes of Health, United States] Recovery Act Limited Competition: Program to Enhance National Institutes of Health-Supported Global Health Research Involving Human Subjects (S07) (RFA-OD-10-006) [National Institutes of Health, United States] Institutional Clinical and Translational Science Award (U54) (RFA-RM-10-001) [National Institutes of Health, United States] Waivers for Conflicts of Interest for the February 22, 2010 Vaccines and Related Biological Products Advisory Committee Meeting [Center for Biologics Evaluation and Research, United States] Notice of Intent to Establish a New National Institutes of Health Common Fund Program: Library of Integrated Network-Based Cellular Signatures (LINCS) (NOT-RM-10-002) [National Institutes of Health, United States] Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (Parent F31) (PA-10-108) [National Institutes of Health, United States] Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships to Promote Diversity in Health-Related Research (Parent F31 – Diversity) (PA-10-109) [National Institutes of Health, United States] Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Postdoctoral Fellows (Parent F32) (PA-10-110) [National Institutes of Health, United States] Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Senior Fellows (Parent F33) (PA-10-111) [National Institutes of Health, United States] Investigator Initiated Multi-Site Clinical Trials (Collaborative R01) (PAR-10-096) [National Heart, Lung, and Blood Institute, United States] Expressions of Interest for Membership of the Therapeutic Goods Committee [Therapeutic Goods Administration, Australia]
|
|
EVENTS American Association for Cancer Research (AACR) 101st Annual Meeting 2010 April 17-21, 2010 Washington, DC, United States Society for Biological Engineering’s (SBE) 2nd International Conference on Stem Cell Engineering May 2-5, 2010 Boston, United States World Stem Cells & Regenerative Medicine Congress 2010 May 11-13, 2010 London, United Kingdom 16th Annual International Society for Cellular Therapy (ISCT) Meeting May 23-26, 2010 Philadelphia, United States Tissue Engineering & Regenerative Medicine International Society (TERMIS) – European Union 2010 June 13-17, 2010 Galway, Ireland International Society for Stem Cell Research (ISSCR) 8th Annual Meeting June 16-19, 2010 San Francisco, United States United Kingdom National Stem Cell Network (UKNSCN) Third Annual Scientific Conference July 12-14, 2010 Nottingham, United Kingdom 3rd Annual Stem Cells Europe August 24-25, 2010 Edinburgh, Scotland 5th World Congress on Preventive & Regenerative Medicine (WCRM) 2010 October 5-7, 2010 Hannover, Germany
JOB OPPORTUNITIES Manufacturing Sciences Technologist – Cell Culture (STEMCELL Technologies) Research & Development Technologist (STEMCELL Technologies) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with ESC & iPSC News. Visit here to post your career opportunities.
|
| |